Key result
Myocarditis linked to ~100% higher prevalence of ventricular antimyosin autoantibodies vs other cardiac diseases.
Why the study?
Autoimmunologic mechanisms and circulating cardiac myosin autoantibodies were shown in animal myocarditis, but their presence in patients with myocarditis required investigation.
Is the prevalence of antimyosin autoantibodies higher in patients with myocarditis compared to healthy controls and patients with other cardiac diseases?
Case-Control (n=134)
Is the prevalence of antimyosin autoantibodies higher in patients with myocarditis compared to healthy controls and patients with other cardiac diseases?
Patients with myocarditis have a significantly higher prevalence of circulating IgG autoantibodies against human ventricular myosin compared to healthy individuals and those with other cardiac diseases, suggesting an autoimmune component in the pathogenesis.
Answers are grounded in this paper and cite their sources.
May indicate autoimmune role in myocarditis; hypothesis-generating and requires prospective validation before diagnostic or therapeutic use.
OBJECTIVES: The present study investigated the presence of antimyosin autoantibodies in sera of patients with myocarditis and in three control groups: healthy blood donors, patients with alcoholic cardiomyopathy and patients with other cardiac diseases. BACKGROUND: An increasing body of evidence indicates that in the course of myocarditis, autoimmunologic mechanisms may play a pathogenetic role. Animal studies with Coxsackie B3 virus-induced murine myocarditis could demonstrate the appearance of circulating autoantibodies against cardiac myosin. METHODS: Sera were analyzed by enzyme-linked immunosorbent assay (ELISA) and Western blot with human left ventricular myosin as antigen. RESULTS: Seventeen (42%) of 40 serum samples from patients with myocarditis showed antibody-binding against myosin, whereas only 1 (2.5%) of 39 samples from healthy blood donors and 9 (21%) of 43 samples from patients with other cardiac diseases showed autoantibodies against myosin (p < 0.05 vs. myocarditis). In sera from patients with alcoholic cardiomyopathy (n = 12), no antibodies against human ventricular myosin could be detected. In Western blots, the antimyosin antibodies in patients with myocarditis bound to the myosin heavy chain. Using protein-A sepharose chromatography, it could be shown that the antimyosin autoantibodies are of the immunoglobulin G (IgG) type. In ELISA, the antimyosin autoantibodies bind equally to myosin prepared from either cardiac or skeletal muscle, respectively. CONCLUSIONS: These results demonstrate the presence of autoantibodies against human ventricular myosin in patients with myocarditis. The prevalence of these autoantibodies is significantly higher in patients with myocarditis than in patients with other cardiac diseases. No organ specificity of the autoantibodies could be detected.
No takes yet. Share an insight, caveat, or question.
Lauer et al. (1994) conducted a case-control in Myocarditis (n=134). Myocarditis vs. Healthy blood donors, alcoholic cardiomyopathy, and other cardiac diseases was evaluated on Presence of autoantibodies against human ventricular myosin (p=<0.05). Myocarditis was associated with a higher prevalence of autoantibodies against human ventricular myosin compared to patients with other cardiac diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: